Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods for generating epitopes for binding to recognition molecules by templated assembly

A composition and biotin technology, applied in chemical instruments and methods, biochemical equipment and methods, medical preparations of non-active ingredients, etc., can solve the problems of finding non-nucleic acid templates, destroying spatial proximity, etc.

Pending Publication Date: 2020-05-08
TRIBIOTICA
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Furthermore, such a design must also account for the possibility of binding associated conformational changes (analogous to allosterism) that could inadvertently disrupt the desired spatial proximity
While these caveats do not preclude testing specific protein choices for templating purposes, they do emphasize the difficulty of finding non-nucleic acid templates in target abnormal cells in a realistic time frame
[0006] Although great strides have been made in the treatment of specific cancers in recent years, many treatment gaps remain

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for generating epitopes for binding to recognition molecules by templated assembly
  • Methods for generating epitopes for binding to recognition molecules by templated assembly
  • Methods for generating epitopes for binding to recognition molecules by templated assembly

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0236] Example 1: Demonstration of co-binding selection on solid-phase targets and sequence confirmation of binary aptamer candidates after co-binding selection

[0237] After 4 separate rounds of selection of the left and right aptamer libraries, the eluted subpopulation was incubated with a biotinylated immunoglobulin Fab target (against the BRD7 protein; ThermoFisher), which was then activated by binding to streptavidin prime magnetic beads to convert to a solid phase. After washing 3 times with 0.5 ml PBSM and once with 1× T4 DNA ligase buffer (NEB, containing 1 mMATP), the preparation was subdivided into two equal parts and splinted with DNA (5′-TCCAGATGTCTTTGCTTTCTTCAGGACACAG (SEQ ID NO: 119); 100 μl, 1 pmol / μl) were + / − annealed by heating at 37°C for 5 min followed by 1 h at room temperature. Thereafter, the preparation was washed an additional 2 times with ligase buffer. Then, the tubes were divided again into two equal parts and treated with + / - T4 DNA ligase. A s...

Embodiment 2

[0240] Example 2: Analysis of single-morphic aptamers and generation of binary aptamers after 10 cycles of selection on Fab fragments (co-binding process)

[0241] After 10 separate selection cycles of monomorphic left and right aptamer subpopulations on biotinylated Fab targets, the resulting subpopulations were cloned and sequenced. Here (compared to the results from the 4th cycle), multiple repetitions of specific aptamer sequences were observed. Three repeats of the specific right aptamer (designated 288 / 10AptR1 ) were seen from 14 sequenced specific single-morphic aptamers (7 each from the left and right clonal populations).

[0242] Then, the 10th cycle subpopulation of left and right aptamers from the Fab target was subjected to a co-binding procedure on the Fab target. The amplified binary products are then sequenced and characterized. The right aptamer clone 228 / 0AptR1 (previously observed as a recurring monomorphic clone) was also found independently in 5 independe...

Embodiment 3

[0245] Example 3: Direct Demonstration of Binding of Specific Generation 10 Singlemorphic Aptamers to Fab Targets

[0246] To assess the binding of the 10th cycle single state aptamer to the selection agent (Fab target), a direct binding assay was performed. Here, single-chain aptamer preparations (usually self-annealing) were incubated in PBSM with or without biotinylated Fab fragments and then adsorbed to streptavidin magnetic beads. After this incubation period, the beads were magnetically separated and the supernatant retained. After 3 washes of the beads, bound material was eluted by a second incubation with 100 μl 0.1 M NaOH 2×20 and the eluate was immediately precipitated with 0.3 M sodium acetate and 3 volumes of ethanol. The precipitate was washed with 70% ethanol and dried. After reconstitution in 5 μl TE, 1 μl samples were denatured in formamide and run on a 10% urea (denaturing) gel. Candidate single state aptamers 228 / 10AptR1 and 229 / 10AptL3 and specific arbitr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
absorbanceaaaaaaaaaa
Login to View More

Abstract

The present disclosure provides polypeptides and polypeptide-nucleic acid conjugates comprising portions of epitopes, and methods of using target molecule binding components, such as aptamers, to present template sequences, where the target molecule binding components bind to target molecules unique to specific cellular targets, for the purpose of templated assembly of the epitopes for recognitionmolecules.

Description

technical field [0001] The present disclosure relates, in part, to polypeptides and polypeptide-nucleic acid conjugates comprising portions of epitopes, and methods of presenting template sequences using target molecule binding components that bind to specific cellular targets. Target molecules for the purpose of templated assembly to recognize epitopes of the molecules. Background technique [0002] The goal of drug development is to deliver effective biotherapeutic interventions to disease-causing cells, such as virus-infected cells, neoplastic cells, cells producing autoimmune responses, and other dysregulated or dysfunctional cells. Examples of effective biotherapeutic interventions capable of combating disease-causing cells include toxins, pro-apoptotic agents, and immunotherapies that redirect immune cells to eliminate disease-causing cells. Unfortunately, the development of these agents is extremely difficult due to the high risk of toxicity to adjacent normal cells ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/00C12N15/115C07K7/00A61K31/713
CPCC07K7/00C07K14/001C12N15/115A61K45/06C12N2310/16C12N2310/3513C07K16/1027C07K16/1235C07K16/18C07K16/2803C07K16/2863C07K16/32C07K2317/34C07K2317/55A61K47/549A61K47/66A61K39/39558A61K2300/00
Inventor 伊恩·邓恩马修·劳勒
Owner TRIBIOTICA